Online Inquiry

Please note that we are not a pharmacy or clinic, so we are unable to see patients and do not offer diagnostic and treatment services for individuals.

BML-260

Inquiry
Cat. No.: OB0425LY-103
Synonyms: 101439-76-3; 4-(5-Benzylidene-4-oxo-2-thioxothiazolidin-3-yl)benzoic acid; Benzoic acid, 4-[4-oxo-5-(phenylmethylene)-2-thioxo-3-thiazolidinyl]-; 4-{4-oxo-5-[1-Phenyl-meth-(Z)-ylidene]-2-thioxo-thiazolidin-3-yl}-benzoic acid
Size: 50 mg; 100 mg; 250 mg
CAS No.: 101439-76-3
Compound CID: 1565747
BML-260

Specification

Description: BML-260 is a potent and dual-specific phosphatases JSP-1 and DUSP22 inhibitor.
Formula Weight: 341.4
Applications: BML-260 can be used to study inflammatory and proliferative diseases associated with JNK signaling dysfunction and obesity.
Storage: Storage at -20°C.
Formula: C17H11NO3S2
Appearance: Solid
Purity: ≥95%
Pathway: JAK/STAT signaling; Stem cell/Wnt; Cell cycle/DNA damage; Metabolic enzyme/Protease; Vitamin D related/Nuclear receptor
Target: STAT; PPAR

Library Information

Inquiry

Copyright © Protheragen. All rights reserves.